12393915	207	Yan F	Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells.	The Journal of biological chemistry	2002	97
16186396	207	Plomgaard P	Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation.	Diabetes	2005	91
17363567	207	Saxena NK	Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells.	Cancer research	2007	106
18649363	207	Li W	Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma.	International journal of cancer	2008	86
20299475	207	Houde VP	Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue.	Diabetes	2010	107
20664791	207	Corby-Harris V	Activation of Akt signaling reduces the prevalence and intensity of malaria parasite infection and lifespan in Anopheles stephensi mosquitoes.	PLoS pathogens	2010	53
22577490	207	Longato L	Insulin resistance, ceramide accumulation, and endoplasmic reticulum stress in human chronic alcohol-related liver disease.	Oxidative medicine and cellular longevity	2012	32
22898879	207	Wu K	Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development.	Hepatology	2012	43
27061150	207	Kim H	Mango polyphenolics reduce inflammation in intestinal colitis-involvement of the miR-126/PI3K/AKT/mTOR axis in vitro and in vivo.	Molecular carcinogenesis	2017	5
8857851	213	Nakeeb A	Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.	Annals of surgery	1996	156
3621347	338	Powell LM	A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine.	Cell	1987	189
17215532	338	Cuchel M	Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia.	The New England journal of medicine	2007	79
18242210	338	Fabbrini E	Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.	Gastroenterology	2008	98
19156195	338	Icard V	Secretion of hepatitis C virus envelope glycoproteins depends on assembly of apolipoprotein B positive lipoproteins.	PloS one	2009	47
19381015	338	Stanhope KL	Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans.	The Journal of clinical investigation	2009	302
20227758	338	Raal FJ	Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial.	Lancet	2010	131
22213436	338	Sullivan S	Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease.	Hepatology	2012	34
23060426	338	Stein EA	Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: results of a randomized, double-blind, placebo-controlled trial to assess efficacy and safety as add-on therapy in patients with coronary artery disease.	Circulation	2012	40
25756439	338	Besseling J	Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus.	JAMA	2015	24
16952647	354	Zelefsky MJ	Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer.	The Journal of urology	2006	71
18755555	354	King CR	Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial.	International journal of radiation oncology, biology, physics	2009	57
20934277	354	Yeoh EE	Hypofractionated versus conventionally fractionated radiotherapy for prostate carcinoma: final results of phase III randomized trial.	International journal of radiation oncology, biology, physics	2011	42
21300474	354	King CR	Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer.	International journal of radiation oncology, biology, physics	2012	79
22330997	354	Zelefsky MJ	Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer.	International journal of radiation oncology, biology, physics	2012	58
20457157	495	Dohil R	Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial.	Gastroenterology	2010	70
2181501	717	Bergman EN	Energy contributions of volatile fatty acids from the gastrointestinal tract in various species.	Physiological reviews	1990	157
27510655	717	Boets E	Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study.	The Journal of physiology	2017	6
10078532	885	Cancela JM	Coordination of agonist-induced Ca2+-signalling patterns by NAADP in pancreatic acinar cells.	Nature	1999	101
11076879	920	Spiller RC	Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome.	Gut	2000	188
14557656	920	Guadalupe M	Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy.	Journal of virology	2003	336
14614606	920	Kamisawa T	A new clinicopathological entity of IgG4-related autoimmune disease.	Journal of gastroenterology	2003	132
15994817	920	Reynolds MR	CD8+ T-lymphocyte response to major immunodominant epitopes after vaginal exposure to simian immunodeficiency virus: too late and too little.	Journal of virology	2005	75
16182404	920	Bräu N	Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy.	Journal of hepatology	2006	89
17570691	920	He B	Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL.	Immunity	2007	180
17959677	920	Sankaran S	Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration.	Journal of virology	2008	82
18260759	920	Chun TW	Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy.	The Journal of infectious diseases	2008	177
18598193	920	Estes J	Collagen deposition limits immune reconstitution in the gut.	The Journal of infectious diseases	2008	63
18664624	920	Brenchley JM	Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections.	Blood	2008	245
19079157	920	Brenchley JM	HIV infection and the gastrointestinal immune system.	Mucosal immunology	2008	132
19079215	920	Macal M	Effective CD4+ T-cell restoration in gut-associated lymphoid tissue of HIV-infected patients is associated with enhanced Th17 cells and polyfunctional HIV-specific T-cell responses.	Mucosal immunology	2008	81
19174797	920	Cremon C	Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.	The American journal of gastroenterology	2009	69
20889546	920	Gordon SN	Disruption of intestinal CD4+ T cell homeostasis is a key marker of systemic CD4+ T cell activation in HIV-infected individuals.	Journal of immunology	2010	48
21378536	920	Chege D	Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation in men on long-term antiretroviral therapy.	AIDS	2011	44
21436711	920	Ellis CL	Molecular characterization of stool microbiota in HIV-infected subjects by panbacterial and order-level 16S ribosomal DNA (rDNA) quantification and correlations with immune activation.	Journal of acquired immune deficiency syndromes	2011	45
21471231	920	Ciccone EJ	CD4+ T cells, including Th17 and cycling subsets, are intact in the gut mucosa of HIV-1-infected long-term nonprogressors.	Journal of virology	2011	35
24180001	920	Pérez-Santiago J	Gut Lactobacillales are associated with higher CD4 and less microbial translocation during HIV infection.	AIDS	2013	28
25586559	920	Klase Z	Dysbiotic bacteria translocate in progressive SIV infection.	Mucosal immunology	2015	28
25908663	920	Hepworth MR	Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4⁺ T cells.	Science	2015	46
26452565	920	Younas M	Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy.	HIV medicine	2016	16
26657141	920	Thome JJ	Early-life compartmentalization of human T cell differentiation and regulatory function in mucosal and lymphoid tissues.	Nature medicine	2016	24
26934227	920	Ma C	NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.	Nature	2016	23
27738167	920	Byrareddy SN	Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy.	Science	2016	20
11118008	966	Hundal RS	Mechanism by which metformin reduces glucose production in type 2 diabetes.	Diabetes	2000	159
19567526	966	Nedeltcheva AV	Exposure to recurrent sleep restriction in the setting of high caloric intake and physical inactivity results in increased insulin resistance and reduced glucose tolerance.	The Journal of clinical endocrinology and metabolism	2009	80
20371664	966	Donga E	A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects.	The Journal of clinical endocrinology and metabolism	2010	73
21656330	966	Lim EL	Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol.	Diabetologia	2011	121
11325821	1029	Issa JP	Accelerated age-related CpG island methylation in ulcerative colitis.	Cancer research	2001	129
12937151	1029	Yang B	Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma.	The American journal of pathology	2003	87
17326708	1029	Galipeau PC	NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma.	PLoS medicine	2007	87
18161048	1029	Nishida N	Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma.	Hepatology	2008	74
18305067	1029	Leedham SJ	Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett's oesophagus.	Gut	2008	56
19966864	1029	Worthley DL	DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer.	Oncogene	2010	42
20146264	1029	Braconi C	MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes.	Hepatology	2010	106
21129377	1029	Vasen HF	Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation.	Gastroenterology	2011	39
22975375	1029	Navas C	EGF receptor signaling is essential for k-ras oncogene-driven pancreatic ductal adenocarcinoma.	Cancer cell	2012	91
23462794	1029	Dayeh TA	Identification of CpG-SNPs associated with type 2 diabetes and differential DNA methylation in human pancreatic islets.	Diabetologia	2013	47
24296717	1029	Dimas AS	Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity.	Diabetes	2014	63
25536104	1029	Churi CR	Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications.	PloS one	2014	40
26950362	1029	Helman A	p16(Ink4a)-induced senescence of pancreatic beta cells enhances insulin secretion.	Nature medicine	2016	19
21949732	1045	Williams BL	Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances.	PloS one	2011	70
22082986	1045	McCracken KW	Generating human intestinal tissue from pluripotent stem cells in vitro.	Nature protocols	2011	60
26022688	1045	Godoy P	Gene networks and transcription factor motifs defining the differentiation of stem cells into hepatocyte-like cells.	Journal of hepatology	2015	23
2494700	1050	Landschulz WH	The DNA binding domain of the rat liver nuclear protein C/EBP is bipartite.	Science	1989	186
12530969	1050	McKay RM	C elegans: a model for exploring the genetics of fat storage.	Developmental cell	2003	103
15677503	1050	Cardozo AK	Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in pancreatic beta-cells.	Diabetes	2005	154
21038412	1050	Zeng C	A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma.	Hepatology	2010	41
23665916	1050	Grøntved L	C/EBP maintains chromatin accessibility in liver and facilitates glucocorticoid receptor recruitment to steroid response elements.	The EMBO journal	2013	40
26076923	1066	Wang X	CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors.	The pharmacogenomics journal	2016	10
11773614	1080	Kunzelmann K	Electrolyte transport in the mammalian colon: mechanisms and implications for disease.	Physiological reviews	2002	119
14762183	1080	Freedman SD	Association of cystic fibrosis with abnormalities in fatty acid metabolism.	The New England journal of medicine	2004	75
15105504	1080	Egan ME	Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects.	Science	2004	97
18083779	1080	De La Fuente R	Small-molecule screen identifies inhibitors of a human intestinal calcium-activated chloride channel.	Molecular pharmacology	2008	61
18675692	1080	Quinton PM	Cystic fibrosis: impaired bicarbonate secretion and mucoviscidosis.	Lancet	2008	82
20110417	1080	Meyerholz DK	Pathology of gastrointestinal organs in a porcine model of cystic fibrosis.	The American journal of pathology	2010	56
21397320	1080	Braganza JM	Chronic pancreatitis.	Lancet	2011	84
21809358	1080	Cardinale V	Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets.	Hepatology	2011	69
23727931	1080	Dekkers JF	A functional CFTR assay using primary cystic fibrosis intestinal organoids.	Nature medicine	2013	86
24040746	1080	Raju SV	Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function.	American journal of respiratory and critical care medicine	2013	35
24315439	1080	Schwank G	Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients.	Cell stem cell	2013	167
24608905	1080	Tuggle KL	Characterization of defects in ion transport and tissue development in cystic fibrosis transmembrane conductance regulator (CFTR)-knockout rats.	PloS one	2014	26
24715669	1080	Dianat N	Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells.	Hepatology	2014	25
24927234	1080	Rowe SM	Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis.	American journal of respiratory and critical care medicine	2014	54
25033378	1080	LaRusch J	Mechanisms of CFTR functional variants that impair regulated bicarbonate permeation and increase risk for pancreatitis but not for cystic fibrosis.	PLoS genetics	2014	27
26167630	1080	Ogawa M	Directed differentiation of cholangiocytes from human pluripotent stem cells.	Nature biotechnology	2015	19
26299960	1080	Firth AL	Functional Gene Correction for Cystic Fibrosis in Lung Epithelial Cells Generated from Patient iPSCs.	Cell reports	2015	21
26677983	1080	Foulke-Abel J	Human Enteroids as a Model of Upper Small Intestinal Ion Transport Physiology and Pathophysiology.	Gastroenterology	2016	16
8608500	1084	Nordlinger B	Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie.	Cancer	1996	222
19152896	1084	Khalid A	Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study.	Gastrointestinal endoscopy	2009	78
21606835	1084	Hartwig W	Pancreatic cancer surgery in the new millennium: better prediction of outcome.	Annals of surgery	2011	63
16728727	1113	Rozengurt N	Colocalization of the alpha-subunit of gustducin with PYY and GLP-1 in L cells of human colon.	American journal of physiology. Gastrointestinal and liver physiology	2006	72
18261235	1113	Immervoll H	Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas.	BMC cancer	2008	59
23066308	1113	El-Salhy M	Irritable bowel syndrome: diagnosis and pathogenesis.	World journal of gastroenterology	2012	49
24316398	1113	El-Salhy M	Abnormal rectal endocrine cells in patients with irritable bowel syndrome.	Regulatory peptides	2014	21
27126040	1113	Zhernakova A	Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity.	Science	2016	53
10221916	1234	Harouse JM	Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs.	Science	1999	128
15365096	1234	Brenchley JM	CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract.	The Journal of experimental medicine	2004	650
16873279	1234	Guadalupe M	Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection.	Journal of virology	2006	96
17147468	1234	Mehandru S	Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection.	PLoS medicine	2006	104
17296858	1234	Wu H	T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity.	Circulation	2007	192
17875002	1234	Zeremski M	The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.	Journal of viral hepatitis	2007	60
20018916	1234	Shimizu S	A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model.	Blood	2010	73
21148083	1234	Allers K	Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation.	Blood	2011	204
24597865	1234	Tebas P	Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.	The New England journal of medicine	2014	257
21103974	1244	Keppler D	Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy.	Handbook of experimental pharmacology	2011	51
15201411	1401	Klein S	Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease.	The New England journal of medicine	2004	113
15472670	1401	Daperno M	Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD.	Gastrointestinal endoscopy	2004	108
16043984	1401	Solem CA	Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease.	Inflammatory bowel diseases	2005	73
16618517	1401	Haukeland JW	Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2.	Journal of hepatology	2006	89
17245566	1401	McMillan DC	Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer.	International journal of colorectal disease	2007	64
17429083	1401	Larsen CM	Interleukin-1-receptor antagonist in type 2 diabetes mellitus.	The New England journal of medicine	2007	415
17533210	1401	Wilson PW	Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study.	Archives of internal medicine	2007	216
17919270	1401	Kajander K	Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.	Alimentary pharmacology and therapeutics	2008	52
18022866	1401	Sipponen T	Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings.	Inflammatory bowel diseases	2008	65
20181810	1401	Bakker GC	An antiinflammatory dietary mix modulates inflammation and oxidative and metabolic stress in overweight men: a nutrigenomics approach.	The American journal of clinical nutrition	2010	42
21530748	1401	Lewis JD	The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease.	Gastroenterology	2011	68
22552027	1401	Queipo-Ortuño MI	Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers.	The American journal of clinical nutrition	2012	49
23216550	1401	Fujimoto T	Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease.	Journal of gastroenterology and hepatology	2013	28
23526699	1401	Verdam FJ	Human intestinal microbiota composition is associated with local and systemic inflammation in obesity.	Obesity	2013	51
23842110	1401	Groeger D	Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut.	Gut microbes	2013	28
23974954	1401	Peyrin-Biroulet L	Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial.	Gut	2014	35
12853196	1432	Maiuri L	Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease.	Lancet	2003	97
20089617	1432	Ma K	12-Lipoxygenase Products Reduce Insulin Secretion and {beta}-Cell Viability in Human Islets.	The Journal of clinical endocrinology and metabolism	2010	43
21144973	1432	Rajesh M	Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.	Journal of the American College of Cardiology	2010	56
16903919	1493	Izcue A	Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation.	Immunological reviews	2006	150
18512248	1493	Hölttä V	IL-23/IL-17 immunity as a hallmark of Crohn's disease.	Inflammatory bowel diseases	2008	52
19198837	1493	Weber J	Ipilimumab: controversies in its development, utility and autoimmune adverse events.	Cancer immunology, immunotherapy 	2009	59
19247441	1493	Nakamoto N	Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade.	PLoS pathogens	2009	113
21205883	1493	Steck AK	Genetics of type 1 diabetes.	Clinical chemistry	2011	40
23341990	1493	Voskens CJ	The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network.	PloS one	2013	45
24388175	1493	Rong Z	An effective approach to prevent immune rejection of human ESC-derived allografts.	Cell stem cell	2014	25
25213377	1493	Kuehn HS	Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4.	Science	2014	83
25601652	1493	Voron T	VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors.	The Journal of experimental medicine	2015	29
25634360	1493	Rosenzwajg M	Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients.	Journal of autoimmunity	2015	24
9990071	1499	Mann B	Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas.	Proceedings of the National Academy of Sciences of the United States of America	1999	180
15592430	1499	Chamorro MN	FGF-20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development.	The EMBO journal	2005	85
15690474	1499	Sirica AE	Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy.	Hepatology	2005	97
15778706	1499	van Es JH	Wnt signalling induces maturation of Paneth cells in intestinal crypts.	Nature cell biology	2005	174
15925592	1499	Pinto D	Wnt control of stem cells and differentiation in the intestinal epithelium.	Experimental cell research	2005	79
17464972	1499	Thompson MD	WNT/beta-catenin signaling in liver health and disease.	Hepatology	2007	126
18006828	1499	Yamashita T	Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma.	Cancer research	2007	113
18519688	1499	Yang W	Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells.	Cancer research	2008	101
19061838	1499	Cairo S	Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer.	Cancer cell	2008	56
22484120	1499	Zhang J	MicroRNA-26a promotes cholangiocarcinoma growth by activating β-catenin.	Gastroenterology	2012	47
22914623	1499	Takada K	Targeted disruption of the BCL9/β-catenin complex inhibits oncogenic Wnt signaling.	Science translational medicine	2012	48
23359139	1499	Kadaba R	Imbalance of desmoplastic stromal cell numbers drives aggressive cancer processes.	The Journal of pathology	2013	28
23463346	1499	Beyoğlu D	Tissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classification.	Hepatology	2013	37
23755105	1499	Papafragkou E	Challenges of culturing human norovirus in three-dimensional organoid intestinal cell culture models.	PloS one	2014	24
23887712	1499	Nault JC	High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions.	Nature communications	2013	82
24837480	1499	Tao J	Activation of β-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice.	Gastroenterology	2014	34
25123931	1499	Wroblewski LE	Helicobacter pylori targets cancer-associated apical-junctional constituents in gastroids and gastric epithelial cells.	Gut	2015	23
15331414	1543	Tateno C	Near completely humanized liver in mice shows human-type metabolic responses to drugs.	The American journal of pathology	2004	80
16467132	1543	Paine MF	The human intestinal cytochrome P450 "pie".	Drug metabolism and disposition	2006	90
19514967	1543	Zhou SF	Polymorphism of human cytochrome P450 enzymes and its clinical impact.	Drug metabolism reviews	2009	86
16176115	1544	Anderson GD	Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach.	Clinical pharmacokinetics	2005	130
19877180	1544	Sullivan GJ	Generation of functional human hepatic endoderm from human induced pluripotent stem cells.	Hepatology	2010	110
8035341	1555	Shimada T	Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.	The Journal of pharmacology and experimental therapeutics	1994	224
20538623	1555	Yang X	Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver.	Genome research	2010	69
14556645	1571	Videla LA	Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients.	Clinical science	2004	73
22271347	1571	D'Ambrosio R	A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis.	Hepatology	2012	36
10852961	1576	Moore LB	St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor.	Proceedings of the National Academy of Sciences of the United States of America	2000	100
16581329	1576	Law M	Statin safety: a systematic review.	The American journal of cardiology	2006	97
17215845	1576	Glaeser H	Intestinal drug transporter expression and the impact of grapefruit juice in humans.	Clinical pharmacology and therapeutics	2007	64
18268015	1576	Takagi S	Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4.	The Journal of biological chemistry	2008	65
19483103	1576	Waxman DJ	Sex differences in the expression of hepatic drug metabolizing enzymes.	Molecular pharmacology	2009	123
19514965	1576	Klotz U	Pharmacokinetics and drug metabolism in the elderly.	Drug metabolism reviews	2009	45
20386561	1576	Wang D	Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs.	The pharmacogenomics journal	2011	81
17116003	1581	Lundåsen T	Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man.	Journal of internal medicine	2006	91
19185005	1581	Schaap FG	High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis.	Hepatology	2009	52
20301097	1581	Touboul T	Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development.	Hepatology	2010	119
23299969	1581	Bechmann LP	Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis.	Hepatology	2013	30
8915011	1670	Zhao C	Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells.	FEBS letters	1996	113
12021776	1670	Ghosh D	Paneth cell trypsin is the processing enzyme for human defensin-5.	Nature immunology	2002	100
12660734	1670	Salzman NH	Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin.	Nature	2003	176
17709525	1670	Wehkamp J	The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4.	Journal of immunology	2007	67
22168415	1670	Lehrer RI	α-Defensins in human innate immunity.	Immunological reviews	2012	83
11487543	1803	van Niel G	Intestinal epithelial cells secrete exosome-like vesicles.	Gastroenterology	2001	140
16517403	1803	Drucker DJ	The biology of incretin hormones.	Cell metabolism	2006	406
16816950	1803	Matikainen N	Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes.	Diabetologia	2006	60
17353295	1803	Wajchenberg BL	beta-cell failure in diabetes and preservation by clinical treatment.	Endocrine reviews	2007	142
17409288	1803	Dunning BE	The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications.	Endocrine reviews	2007	79
18786299	1803	DeFronzo RA	Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon secretion, gastric emptying, and caloric intake: a randomized, cross-over study.	Current medical research and opinion	2008	82
21205122	1803	Del Prato S	Effect of linagliptin monotherapy on glycaemic control and markers of β-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial.	Diabetes, obesity and metabolism	2011	69
21824266	1803	D'Alessio D	The role of dysregulated glucagon secretion in type 2 diabetes.	Diabetes, obesity and metabolism	2011	48
23818527	1803	Drucker DJ	Incretin action in the pancreas: potential promise, possible perils, and pathological pitfalls.	Diabetes	2013	57
25326803	1803	Watson CL	An in vivo model of human small intestine using pluripotent stem cells.	Nature medicine	2014	58
26489970	1803	Nauck M	Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors.	Diabetes, obesity and metabolism	2016	14
10684852	1861	Arentz-Hansen H	The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase.	The Journal of experimental medicine	2000	118
21224837	1861	Biesiekierski JR	Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial.	The American journal of gastroenterology	2011	94
22432018	1861	Sellitto M	Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants.	PloS one	2012	46
24216570	1861	Aziz I	A UK study assessing the population prevalence of self-reported gluten sensitivity and referral characteristics to secondary care.	European journal of gastroenterology and hepatology	2014	23
25157096	1861	Pathiraja V	Proinsulin-specific, HLA-DQ8, and HLA-DQ8-transdimer-restricted CD4+ T cells infiltrate islets in type 1 diabetes.	Diabetes	2015	18
16183912	1950	Bouwens L	Regulation of pancreatic beta-cell mass.	Physiological reviews	2005	111
25924068	1950	Drost J	Sequential cancer mutations in cultured human intestinal stem cells.	Nature	2015	71
12435727	1956	Andl CD	Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal keratinocytes in vitro and in vivo.	The Journal of biological chemistry	2003	90
16020518	1956	Means AL	Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates.	Development	2005	106
17030071	1956	Malhi H	Cholangiocarcinoma: modern advances in understanding a deadly old disease.	Journal of hepatology	2006	65
17050876	1956	Dragovich T	Phase II trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas: SWOG 0127.	Journal of clinical oncology 	2006	75
17974918	1956	Okawa T	The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation.	Genes and development	2007	65
18087285	1956	Yoshikawa D	Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma.	British journal of cancer	2008	79
20736298	1956	Cameron D	Lapatinib plus capecitabine in women with HER-2-positive advanced breast cancer: final survival analysis of a phase III randomized trial.	The oncologist	2010	49
21253578	1956	Gu TL	Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma.	PloS one	2011	89
21468131	1956	Okines A	Targeting the human EGFR family in esophagogastric cancer.	Nature reviews. Clinical oncology	2011	43
22178589	1956	Andersen JB	Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors.	Gastroenterology	2012	76
23391413	1956	Voss JS	Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions.	Human pathology	2013	38
23584089	1956	Sadanandam A	A colorectal cancer classification system that associates cellular phenotype and responses to therapy.	Nature medicine	2013	186
24550739	1956	Borad MJ	Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma.	PLoS genetics	2014	55
24677197	1956	Fuchs BC	Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.	Hepatology	2014	60
25573908	1956	Kopp JB	Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical Trial.	Journal of the American Society of Nephrology 	2015	22
25682441	1956	Fuse N	Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients.	Gastric cancer 	2016	19
20728210	2064	Bang YJ	Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.	Lancet	2010	956
22222640	2064	Rüschoff J	HER2 testing in gastric cancer: a practical approach.	Modern pathology 	2012	80
22257673	2064	Baselga J	Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial.	Lancet	2012	207
22689179	2064	Janjigian YY	Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis.	Annals of oncology 	2012	46
24337604	2064	Mortimer JE	Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using (64)Cu-DOTA-trastuzumab PET.	Journal of nuclear medicine 	2014	28
24665085	2064	Sörensen J	First-in-human molecular imaging of HER2 expression in breast cancer metastases using the 111In-ABY-025 affibody molecule.	Journal of nuclear medicine 	2014	36
25038874	2064	Van Cutsem E	HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer.	Gastric cancer 	2015	23
26628478	2064	Hecht JR	Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC--A Randomized Phase III Trial.	Journal of clinical oncology 	2016	58
27156933	2064	Van Cutsem E	Gastric cancer.	Lancet	2016	35
17241857	2147	Barbara G	Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome.	Gastroenterology	2007	132
19717844	2147	Connolly SJ	Dabigatran versus warfarin in patients with atrial fibrillation.	The New England journal of medicine	2009	1020
11435577	2158	Nakai H	Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo.	Journal of virology	2001	98
16322469	2158	Nathwani AC	Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver.	Blood	2006	111
16474400	2158	Manno CS	Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response.	Nature medicine	2006	528
16868252	2158	Jiang H	Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy.	Blood	2006	99
17090654	2158	Nathwani AC	Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates.	Blood	2007	97
17609423	2158	Mingozzi F	Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver.	Blood	2007	72
17979678	2158	Mingozzi F	Immune responses to AAV in clinical trials.	Current gene therapy	2007	76
21245849	2158	Nathwani AC	Long-term safety and efficacy following systemic administration of a self-complementary AAV vector encoding human FIX pseudotyped with serotype 5 and 8 capsid proteins.	Molecular therapy 	2011	79
25419787	2158	Monahan PE	Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: preclinical evaluation supporting an ongoing adeno-associated virus clinical trial.	Human gene therapy	2015	16
26302233	2158	Su J	Low cost industrial production of coagulation factor IX bioencapsulated in lettuce cells for oral tolerance induction in hemophilia B.	Biomaterials	2015	22
23660579	2169	Asmuth DM	Oral serum-derived bovine immunoglobulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy.	AIDS	2013	25
23818854	2169	Chevalier MF	The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation.	PLoS pathogens	2013	35
10409121	2305	Winder WW	AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes.	The American journal of physiology	1999	155
10868964	2305	Hohmeier HE	Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion.	Diabetes	2000	284
17149590	2305	Wang H	MAFA controls genes implicated in insulin biosynthesis and secretion.	Diabetologia	2007	58
22613004	2305	Xia L	Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.	Journal of hepatology	2012	34
23297075	2305	Wu Z	Development and evaluation of 18F-TTCO-Cys40-Exendin-4: a PET probe for imaging transplanted islets.	Journal of nuclear medicine 	2013	29
11588036	2335	Campagnoli C	Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow.	Blood	2001	230
12815434	2335	Sakai T	Fibronectin requirement in branching morphogenesis.	Nature	2003	150
15173316	2335	D'Ippolito G	Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential.	Journal of cell science	2004	134
19079190	2335	Blanchard C	Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses.	Mucosal immunology	2008	68
22465212	2335	Kagalwalla AF	Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment.	The Journal of allergy and clinical immunology	2012	39
25795669	2335	Reunanen J	Akkermansia muciniphila Adheres to Enterocytes and Strengthens the Integrity of the Epithelial Cell Layer.	Applied and environmental microbiology	2015	31
15604215	2475	Khamzina L	Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.	Endocrinology	2005	141
17287212	2475	Gleason CE	The role of AMPK and mTOR in nutrient sensing in pancreatic beta-cells.	The Journal of biological chemistry	2007	56
18174523	2475	Fraenkel M	mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes.	Diabetes	2008	95
18393362	2475	Yin XM	Autophagy in the liver.	Hepatology	2008	69
20664473	2475	Boudreaux JP	The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum.	Pancreas	2010	53
21269838	2475	Howell JJ	mTOR couples cellular nutrient sensing to organismal metabolic homeostasis.	Trends in endocrinology and metabolism	2011	107
22449814	2475	Bakan I	Connecting mTORC1 signaling to SREBP-1 activation.	Current opinion in lipidology	2012	36
23832089	2475	Pajvani UB	Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability.	Nature medicine	2013	32
23881200	2475	Barlow AD	Evidence for rapamycin toxicity in pancreatic β-cells and a review of the underlying molecular mechanisms.	Diabetes	2013	28
23929677	2475	Sinha RA	Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice.	Hepatology	2014	36
24556859	2475	Bernal-Mizrachi E	Human β-cell proliferation and intracellular signaling part 2: still driving in the dark without a road map.	Diabetes	2014	43
24606899	2475	Solon-Biet SM	The ratio of macronutrients, not caloric intake, dictates cardiometabolic health, aging, and longevity in ad libitum-fed mice.	Cell metabolism	2014	121
25554914	2475	Albert V	mTOR signaling in cellular and organismal energetics.	Current opinion in cell biology	2015	49
25902704	2475	Longo VD	Interventions to Slow Aging in Humans: Are We Ready?	Aging cell	2015	58
26463117	2475	Arriola Apelo SI	Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system.	Aging cell	2016	12
26627594	2475	Qian P	The Dlk1-Gtl2 Locus Preserves LT-HSC Function by Inhibiting the PI3K-mTOR Pathway to Restrict Mitochondrial Metabolism.	Cell stem cell	2016	13
22359255	2520	Jacobsen SH	Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.	Obesity surgery	2012	40
19587243	2538	Samuel VT	Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2009	47
20159955	2538	Schmutz I	The mammalian clock component PERIOD2 coordinates circadian output by interaction with nuclear receptors.	Genes and development	2010	107
20699420	2571	Keenan HA	Residual insulin production and pancreatic ß-cell turnover after 50 years of diabetes: Joslin Medalist Study.	Diabetes	2010	92
19741189	2572	Orban T	Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1.	Diabetes care	2009	82
23780460	2572	Ziegler AG	Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.	JAMA	2013	102
11897280	2641	Zander M	Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study.	Lancet	2002	188
12540611	2641	Kjems LL	The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects.	Diabetes	2003	89
12554744	2641	Drucker DJ	Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.	Molecular endocrinology	2003	85
12788877	2641	Vilsbøll T	Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.	The Journal of clinical endocrinology and metabolism	2003	89
12960095	2641	Farilla L	Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.	Endocrinology	2003	113
15111485	2641	Degn KB	One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha- and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes.	Diabetes	2004	71
15919803	2641	Franklin I	Beta-cell secretory products activate alpha-cell ATP-dependent potassium channels to inhibit glucagon release.	Diabetes	2005	74
16219666	2641	Theodorakis MJ	Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.	American journal of physiology. Endocrinology and metabolism	2006	72
17715056	2641	Parthier C	Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor.	Proceedings of the National Academy of Sciences of the United States of America	2007	84
17994216	2641	Parnaud G	Proliferation of sorted human and rat beta cells.	Diabetologia	2008	83
18393659	2641	Kellett GL	Sugar absorption in the intestine: the role of GLUT2.	Annual review of nutrition	2008	68
20130660	2641	Tarini J	The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects.	Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme	2010	45
20876708	2641	Musso G	Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?	Diabetes care	2010	105
21048796	2641	Thatava T	Indolactam V/GLP-1-mediated differentiation of human iPS cells into glucose-responsive insulin-secreting progeny.	Gene therapy	2011	37
21697254	2641	DeFronzo RA	Preservation of β-cell function: the key to diabetes prevention.	The Journal of clinical endocrinology and metabolism	2011	53
21868791	2641	Salehi M	Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans.	Diabetes	2011	67
22467277	2641	Nobili V	Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease.	Hepatology	2012	31
22538359	2641	Dirksen C	Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.	Diabetologia	2012	35
22899902	2641	Suzuki K	Obesity and appetite control.	Experimental diabetes research	2012	30
22965295	2641	Marchetti P	A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets.	Diabetologia	2012	32
23183535	2641	Thatava T	Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells.	Molecular therapy 	2013	26
23187122	2641	Bradley D	Gastric bypass and banding equally improve insulin sensitivity and β cell function.	The Journal of clinical investigation	2012	52
23377698	2641	Calanna S	Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies.	Diabetologia	2013	29
23649520	2641	Jørgensen NB	Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes.	Diabetes	2013	44
24161075	2641	Drucker DJ	Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2.	Annual review of physiology	2014	24
24315990	2641	Salehi M	Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass.	Gastroenterology	2014	22
24988476	2641	Napolitano A	Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus.	PloS one	2014	28
25500202	2641	Chambers ES	Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults.	Gut	2015	48
26394161	2641	Armstrong MJ	Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis.	Journal of hepatology	2016	13
18726182	2645	Iynedjian PB	Molecular physiology of mammalian glucokinase.	Cellular and molecular life sciences 	2009	77
19643913	2645	Beer NL	The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver.	Human molecular genetics	2009	97
21459328	2645	Porat S	Control of pancreatic β cell regeneration by glucose metabolism.	Cell metabolism	2011	108
24257076	2645	Bruin JE	Characterization of polyhormonal insulin-producing cells derived in vitro from human embryonic stem cells.	Stem cell research	2014	25
26577716	2645	Ohn JH	10-year trajectory of β-cell function and insulin sensitivity in the development of type 2 diabetes: a community-based prospective cohort study.	The lancet. Diabetes and endocrinology	2016	16
22134839	2695	Beysen C	Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study.	Diabetologia	2012	31
23684623	2695	Campbell JE	Pharmacology, physiology, and mechanisms of incretin hormone action.	Cell metabolism	2013	128
24018562	2695	Hodson DJ	Lipotoxicity disrupts incretin-regulated human β cell connectivity.	The Journal of clinical investigation	2013	42
12469359	2740	Straub SG	Glucose-stimulated signaling pathways in biphasic insulin secretion.	Diabetes/metabolism research and reviews	2002	84
18162504	2740	Muscelli E	Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients.	Diabetes	2008	64
18287102	2740	Runge S	Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain.	The Journal of biological chemistry	2008	101
19442172	2740	Cani PD	The role of the gut microbiota in energy metabolism and metabolic disease.	Current pharmaceutical design	2009	138
20029383	2740	Kashyap SR	Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes.	International journal of obesity	2010	56
22338093	2740	Nyborg NC	The human GLP-1 analog liraglutide and the pancreas: evidence for the absence of structural pancreatic changes in three species.	Diabetes	2012	31
24467746	2740	Pyke C	GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody.	Endocrinology	2014	53
9819447	2875	Davis GL	Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.	The New England journal of medicine	1998	152
10210705	2875	Kenny-Walsh E	Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group.	The New England journal of medicine	1999	144
12606734	2875	Hadziyannis SJ	Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.	The New England journal of medicine	2003	131
14512888	2875	Neuschwander-Tetri BA	Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone.	Hepatology	2003	99
15639293	2875	Janssen HL	Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial.	Lancet	2005	150
17021358	2875	Saukkonen JJ	An official ATS statement: hepatotoxicity of antituberculosis therapy.	American journal of respiratory and critical care medicine	2006	137
17439526	2875	Coco B	Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases.	Journal of viral hepatitis	2007	108
17595248	2875	Kotronen A	Liver fat in the metabolic syndrome.	The Journal of clinical endocrinology and metabolism	2007	70
18421281	2875	Larson-Meyer DE	Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function.	Obesity	2008	53
18673426	2875	Chan HL	Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B.	Journal of viral hepatitis	2009	66
18752331	2875	Fracanzani AL	Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.	Hepatology	2008	95
18945255	2875	Loomba R	Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis.	Alimentary pharmacology and therapeutics	2009	48
19585618	2875	Feldstein AE	Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study.	Hepatology	2009	123
20858492	2875	Williams CD	Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.	Gastroenterology	2011	346
21846782	2875	Wong VW	Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography.	Gut	2012	62
21953442	2875	Kowdley KV	Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease.	Hepatology	2012	65
22023985	2875	Parker HM	Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis.	Journal of hepatology	2012	73
22266604	2875	Antoine DJ	Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity.	Journal of hepatology	2012	103
22546742	2875	Karlsson CL	The microbiota of the gut in preschool children with normal and excessive body weight.	Obesity	2012	64
23696515	2875	Noureddin M	Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials.	Hepatology	2013	53
24187469	2875	Ma YY	Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.	World journal of gastroenterology	2013	46
24316260	2875	Lambert JE	Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease.	Gastroenterology	2014	63
25311610	2875	Faghihzadeh F	Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease.	Nutrition research	2014	24
25873639	2875	Kwok R	Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study.	Gut	2016	13
11473047	3077	Marchesini G	Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.	Diabetes	2001	377
19254567	3077	Gao J	Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression.	Cell metabolism	2009	93
19931264	3077	Valenti L	HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.	Gastroenterology	2010	47
2531289	3082	Nakamura T	Molecular cloning and expression of human hepatocyte growth factor.	Nature	1989	282
12865405	3082	Kollet O	HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver.	The Journal of clinical investigation	2003	127
15562440	3082	Lee KD	In vitro hepatic differentiation of human mesenchymal stem cells.	Hepatology	2004	168
24965569	3082	Iveson T	Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study.	The Lancet. Oncology	2014	72
14988562	3172	Odom DT	Control of pancreas and liver gene expression by HNF transcription factors.	Science	2004	407
18301398	3172	Murphy R	Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes.	Nature clinical practice. Endocrinology and metabolism	2008	83
21852396	3172	DeLaForest A	HNF4A is essential for specification of hepatic progenitors from human pluripotent stem cells.	Development	2011	49
2195544	3375	Westermark P	Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation.	Proceedings of the National Academy of Sciences of the United States of America	1990	148
3317417	3375	Cooper GJ	Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients.	Proceedings of the National Academy of Sciences of the United States of America	1987	172
17475933	3375	Huang CJ	High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes.	Diabetes	2007	127
18408164	3375	Engel MF	Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane.	Proceedings of the National Academy of Sciences of the United States of America	2008	106
18442979	3375	Apostolidou M	Structure of alpha-helical membrane-bound human islet amyloid polypeptide and its implications for membrane-mediated misfolding.	The Journal of biological chemistry	2008	62
18556473	3375	Wiltzius JJ	Atomic structure of the cross-beta spine of islet amyloid polypeptide (amylin).	Protein science 	2008	76
19244249	3375	Patil SM	Dynamic alpha-helix structure of micelle-bound human amylin.	The Journal of biological chemistry	2009	49
20042670	3375	Gurlo T	Evidence for proteotoxicity in beta cells in type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway.	The American journal of pathology	2010	59
20182863	3375	Zraika S	Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence?	Diabetologia	2010	45
21742788	3375	Westermark P	Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.	Physiological reviews	2011	152
21942864	3375	Brender JR	Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective.	Accounts of chemical research	2012	63
24374217	3375	Kameswaran V	Epigenetic regulation of the DLK1-MEG3 microRNA cluster in human type 2 diabetic islets.	Cell metabolism	2014	52
25036705	3375	Kim J	Amyloidogenic peptide oligomer accumulation in autophagy-deficient β cells induces diabetes.	The Journal of clinical investigation	2014	24
17353365	3439	Dunn C	Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage.	The Journal of experimental medicine	2007	102
20335250	3439	Mordstein M	Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections.	Journal of virology	2010	98
21800339	3439	Marukian S	Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures.	Hepatology	2011	85
8536356	3458	Duchmann R	Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)	Clinical and experimental immunology	1995	157
8993017	3458	D'Elios MM	T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease.	Journal of immunology	1997	135
10352304	3458	Pizarro TT	IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells.	Journal of immunology	1999	99
10646872	3458	Jaiswal M	Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism.	Cancer research	2000	104
14555512	3458	Ichihara F	Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers.	Clinical cancer research 	2003	97
15100412	3458	Wieland S	Genomic analysis of the host response to hepatitis B virus infection.	Proceedings of the National Academy of Sciences of the United States of America	2004	143
15479680	3458	Hart AL	Modulation of human dendritic cell phenotype and function by probiotic bacteria.	Gut	2004	93
15537905	3458	Mannon PJ	Anti-interleukin-12 antibody for active Crohn's disease.	The New England journal of medicine	2004	154
17590175	3458	Shioya M	Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease.	Clinical and experimental immunology	2007	60
17655740	3458	Zeuthen LH	Epithelial cells prime the immune response to an array of gut-derived commensals towards a tolerogenic phenotype through distinct actions of thymic stromal lymphopoietin and transforming growth factor-beta.	Immunology	2008	57
18497880	3458	Kamada N	Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis.	The Journal of clinical investigation	2008	139
18684007	3458	Cranage M	Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel.	PLoS medicine	2008	72
19538319	3458	Schulzke JD	Epithelial tight junctions in intestinal inflammation.	Annals of the New York Academy of Sciences	2009	70
19542050	3458	Gao B	Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases.	Journal of leukocyte biology	2009	93
19740775	3458	Rovedatti L	Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease.	Gut	2009	67
19747917	3458	Ahlenstiel G	Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner.	Gastroenterology	2010	91
19818653	3458	Feuerer M	How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets.	Immunity	2009	83
19940845	3458	Hill DA	Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis.	Mucosal immunology	2010	121
21102458	3458	Wilhelm K	Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R.	Nature medicine	2010	95
21187913	3458	Peppa D	Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection.	PLoS pathogens	2010	64
24967632	3458	Jo J	Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver.	PLoS pathogens	2014	29
25387892	3458	Chen S	Combination of 4-1BB agonist and PD-1 antagonist promotes antitumor effector/memory CD8 T cells in a poorly immunogenic tumor model.	Cancer immunology research	2015	17
25644696	3458	Jiang W	Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease.	Scientific reports	2015	23
8403503	3553	Reinecker HC	Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.	Clinical and experimental immunology	1993	157
11058758	3553	Fournier T	Alpha-1-acid glycoprotein.	Biochimica et biophysica acta	2000	114
12235117	3553	Maedler K	Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets.	The Journal of clinical investigation	2002	229
12441323	3553	Figueiredo C	Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma.	Journal of the National Cancer Institute	2002	144
16503465	3553	Marks DJ	Defective acute inflammation in Crohn's disease: a clinical investigation.	Lancet	2006	104
17853946	3553	Schenk M	TREM-1--expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases.	The Journal of clinical investigation	2007	73
18227479	3553	Donath MY	Islet inflammation in type 2 diabetes: from metabolic stress to therapy.	Diabetes care	2008	81
18664535	3553	Böni-Schnetzler M	Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation.	The Journal of clinical endocrinology and metabolism	2008	58
19542207	3553	Larsen CM	Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes.	Diabetes care	2009	87
19842207	3553	Zhang JY	Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B.	Hepatology	2010	89
20398664	3553	Ng J	Clostridium difficile toxin-induced inflammation and intestinal injury are mediated by the inflammasome.	Gastroenterology	2010	54
20588114	3553	Dinarello CA	Role of IL-1beta in type 2 diabetes.	Current opinion in endocrinology, diabetes, and obesity	2010	74
22412385	3553	Eizirik DL	The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines.	PLoS genetics	2012	82
22415665	3553	Hoque R	Sterile inflammatory response in acute pancreatitis.	Pancreas	2012	32
22891275	3553	Coccia M	IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells.	The Journal of experimental medicine	2012	93
23139215	3553	Ganguli K	Probiotics prevent necrotizing enterocolitis by modulating enterocyte genes that regulate innate immune-mediated inflammation.	American journal of physiology. Gastrointestinal and liver physiology	2013	40
24133185	3553	Allers K	Macrophages accumulate in the gut mucosa of untreated HIV-infected patients.	The Journal of infectious diseases	2014	22
24203055	3553	Uhlig HH	Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease.	Gut	2013	39
24497828	3553	Sereti I	Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration.	PLoS pathogens	2014	32
25057045	3553	Dinh DM	Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection.	The Journal of infectious diseases	2015	56
26187413	3553	Bernink JH	Interleukin-12 and -23 Control Plasticity of CD127(+) Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria.	Immunity	2015	37
26668389	3553	Kim HJ	Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip.	Proceedings of the National Academy of Sciences of the United States of America	2016	39
2444978	3569	Gauldie J	Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.	Proceedings of the National Academy of Sciences of the United States of America	1987	261
15313862	3569	St John MA	Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma.	Archives of otolaryngology--head and neck surgery	2004	80
16012934	3569	Hart AL	Characteristics of intestinal dendritic cells in inflammatory bowel diseases.	Gastroenterology	2005	95
17114290	3569	Petersen KF	Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men.	Proceedings of the National Academy of Sciences of the United States of America	2006	82
17241887	3569	Isomoto H	Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing.	Gastroenterology	2007	64
17716366	3569	Jeschke MG	Burn size determines the inflammatory and hypermetabolic response.	Critical care	2007	58
18776137	3569	Miao F	Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes.	Diabetes	2008	53
19318968	3569	Tarantino G	Could inflammatory markers help diagnose nonalcoholic steatohepatitis?	European journal of gastroenterology and hepatology	2009	46
19585655	3569	Marra F	Adipokines in liver diseases.	Hepatology	2009	93
20125064	3569	Park KS	Trophic molecules derived from human mesenchymal stem cells enhance survival, function, and angiogenesis of isolated islets after transplantation.	Transplantation	2010	52
20581244	3569	Wong VW	Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years.	Gut	2010	87
21042596	3569	Bertola A	Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients.	PloS one	2010	47
21726511	3569	Sandler NG	Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection.	Gastroenterology	2011	90
22411804	3569	Villenave R	In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2012	46
22821944	3569	Bajaj JS	Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation.	American journal of physiology. Gastrointestinal and liver physiology	2012	72
23038174	3569	Martínez I	Gut microbiome composition is linked to whole grain-induced immunological improvements.	The ISME journal	2013	54
23160966	3569	Piya MK	Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin.	The Journal of endocrinology	2013	37
23482247	3569	Basaranoglu M	Fructose as a key player in the development of fatty liver disease.	World journal of gastroenterology	2013	44
24117923	3569	Xiao S	A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome.	FEMS microbiology ecology	2014	36
24390544	3569	Chang PV	The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition.	Proceedings of the National Academy of Sciences of the United States of America	2014	115
24828436	3569	Bala S	Acute binge drinking increases serum endotoxin and bacterial DNA levels in healthy individuals.	PloS one	2014	38
24841946	3569	Lleo A	Shotgun proteomics: identification of unique protein profiles of apoptotic bodies from biliary epithelial cells.	Hepatology	2014	23
24910242	3569	Umemura A	Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition.	Cell metabolism	2014	22
25387317	3569	Somsouk M	Gut epithelial barrier and systemic inflammation during chronic HIV infection.	AIDS	2015	26
25731872	3569	Dubuquoy L	Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis.	Gut	2015	15
25888319	3569	Ramis IB	Polymorphisms of the IL-6, IL-8 and IL-10 genes and the risk of gastric pathology in patients infected with Helicobacter pylori.	Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi	2017	5
7729872	3576	Sharma SA	Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro.	Infection and immunity	1995	115
10823949	3576	Nanthakumar NN	Inflammation in the developing human intestine: A possible pathophysiologic contribution to necrotizing enterocolitis.	Proceedings of the National Academy of Sciences of the United States of America	2000	94
12474223	3576	Banks C	Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.	The Journal of pathology	2003	77
12496258	3576	Heidemann J	Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2.	The Journal of biological chemistry	2003	117
15521010	3576	Vavricka SR	hPepT1 transports muramyl dipeptide, activating NF-kappaB and stimulating IL-8 secretion in human colonic Caco2/bbe cells.	Gastroenterology	2004	72
18524406	3576	Candela M	Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production.	International journal of food microbiology	2008	55
21731723	3576	Zimmermann HW	Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis.	PloS one	2011	54
22020518	3576	Lebeer S	Functional analysis of Lactobacillus rhamnosus GG pili in relation to adhesion and immunomodulatory interactions with intestinal epithelial cells.	Applied and environmental microbiology	2012	47
12477762	3605	Fujino S	Increased expression of interleukin 17 in inflammatory bowel disease.	Gut	2003	356
18684981	3605	Sakai A	Identification of IL-18 and Th17 cells in salivary glands of patients with Sjögren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18.	Journal of immunology	2008	61
19700754	3605	Katsifis GE	Systemic and local interleukin-17 and linked cytokines associated with Sjögren's syndrome immunopathogenesis.	The American journal of pathology	2009	54
19701202	3605	Wu S	A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses.	Nature medicine	2009	321
19936899	3605	Eastaff-Leung N	Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease.	Journal of clinical immunology	2010	74
20592279	3605	Honkanen J	IL-17 immunity in human type 1 diabetes.	Journal of immunology	2010	66
21147109	3605	Hovhannisyan Z	Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases.	Gastroenterology	2011	73
21297998	3605	Sobhani I	Microbial dysbiosis in colorectal cancer (CRC) patients.	PloS one	2011	135
22643849	3605	Klatt NR	Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection.	Mucosal immunology	2012	66
24097227	3605	Ueno A	Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients.	Inflammatory bowel diseases	2013	38
25961452	3605	Burkett PR	Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity.	The Journal of clinical investigation	2015	24
26829644	3605	Ryan ES	Loss of Function of Intestinal IL-17 and IL-22 Producing Cells Contributes to Inflammation and Viral Persistence in SIV-Infected Rhesus Macaques.	PLoS pathogens	2016	13
27102666	3605	Chen J	An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis.	Genome medicine	2016	16
3288530	3630	Ricordi C	Automated method for isolation of human pancreatic islets.	Diabetes	1988	205
3514343	3630	Nauck M	Reduced incretin effect in type 2 (non-insulin-dependent) diabetes.	Diabetologia	1986	177
3899825	3630	Matthews DR	Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.	Diabetologia	1985	4427
8247074	3630	Lillioja S	Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians.	The New England journal of medicine	1993	204
10189543	3630	-	The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes.	Diabetes care	1999	180
10209084	3630	Andrews RC	Glucocorticoids and insulin resistance: old hormones, new targets.	Clinical science	1999	100
11812755	3630	Vozarova B	High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes.	Diabetes	2002	84
11826410	3630	Pagano G	Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association.	Hepatology	2002	105
11872682	3630	Mayerson AB	The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes.	Diabetes	2002	98
12037147	3630	Diabetes Prevention Trial--Type 1 Diabetes Study Group.	Effects of insulin in relatives of patients with type 1 diabetes mellitus.	The New England journal of medicine	2002	136
12196473	3630	Buchanan TA	Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women.	Diabetes	2002	184
12606496	3630	Robertson RP	Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection.	Diabetes	2003	124
12610045	3630	Steffes MW	Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial.	Diabetes care	2003	135
12750520	3630	Petersen KF	Mitochondrial dysfunction in the elderly: possible role in insulin resistance.	Science	2003	450
14693724	3630	Palmer JP	C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.	Diabetes	2004	112
15292279	3630	Hull RL	Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes.	The Journal of clinical endocrinology and metabolism	2004	122
15564314	3630	Gershengorn MC	Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells.	Science	2004	100
15662003	3630	Rhodes CJ	Type 2 diabetes-a matter of beta-cell life and death?	Science	2005	195
15734833	3630	Petersen KF	Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes.	Diabetes	2005	183
15747110	3630	Bugianesi E	Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms.	Diabetologia	2005	109
16046308	3630	Kitabchi AE	Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin.	Diabetes	2005	130
16456680	3630	Yki-Järvinen H	Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study.	Diabetologia	2006	83
16567536	3630	Festa A	The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study.	Diabetes	2006	73
16824015	3630	Heit JJ	Intrinsic regulators of pancreatic beta-cell proliferation.	Annual review of cell and developmental biology	2006	76
16968800	3630	Utzschneider KM	Review: The role of insulin resistance in nonalcoholic fatty liver disease.	The Journal of clinical endocrinology and metabolism	2006	97
17130651	3630	Morino K	Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction.	Diabetes	2006	192
17158419	3630	Lê KA	A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans.	The American journal of clinical nutrition	2006	76
17261637	3630	Gromada J	Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains.	Endocrine reviews	2007	149
17341552	3630	Cobelli C	Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests.	American journal of physiology. Endocrinology and metabolism	2007	75
17666486	3630	Bertram R	Metabolic and electrical oscillations: partners in controlling pulsatile insulin secretion.	American journal of physiology. Endocrinology and metabolism	2007	69
17684197	3630	Zivkovic AM	Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease.	The American journal of clinical nutrition	2007	75
17981116	3630	Pospisilik JA	Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes.	Cell	2007	143
18288110	3630	Kroon E	Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo.	Nature biotechnology	2008	489
18434349	3630	Macfarlane DP	Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome.	The Journal of endocrinology	2008	64
18436705	3630	Scheuner D	The unfolded protein response: a pathway that links insulin demand with beta-cell failure and diabetes.	Endocrine reviews	2008	153
18474251	3630	Kotronen A	Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.	Gastroenterology	2008	52
18502299	3630	Weng J	Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.	Lancet	2008	134
18802479	3630	Skowera A	CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope.	The Journal of clinical investigation	2008	115
18834431	3630	Rahier J	Pancreatic beta-cell mass in European subjects with type 2 diabetes.	Diabetes, obesity and metabolism	2008	173
19196887	3630	Bunck MC	One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial.	Diabetes care	2009	105
19223251	3630	Petta S	Non-alcoholic fatty liver disease pathogenesis: the present and the future.	Digestive and liver disease 	2009	48
19332493	3630	Brøns C	Impact of short-term high-fat feeding on glucose and insulin metabolism in young healthy men.	The Journal of physiology	2009	50
19515410	3630	Tabák AG	Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study.	Lancet	2009	150
19637289	3630	Johnson NA	Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss.	Hepatology	2009	88
19742322	3630	Kuroda A	Insulin gene expression is regulated by DNA methylation.	PloS one	2009	61
20022465	3630	Das UN	Obesity: genes, brain, gut, and environment.	Nutrition	2010	45
20086073	3630	Tappy L	Metabolic effects of fructose and the worldwide increase in obesity.	Physiological reviews	2010	188
20181961	3630	Bhandare R	Genome-wide analysis of histone modifications in human pancreatic islets.	Genome research	2010	53
20212498	3630	Calvani R	Gut microbiome-derived metabolites characterize a peculiar obese urinary metabotype.	International journal of obesity	2010	40
20480025	3630	Hanhineva K	Impact of dietary polyphenols on carbohydrate metabolism.	International journal of molecular sciences	2010	69
20522594	3630	Kars M	Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women.	Diabetes	2010	93
20724178	3630	Liu M	Proinsulin misfolding and diabetes: mutant INS gene-induced diabetes of youth.	Trends in endocrinology and metabolism	2010	43
20798346	3630	Unger RH	Paracrinology of islets and the paracrinopathy of diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2010	67
20978091	3630	Schauer IE	Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study.	Diabetes	2011	48
21050286	3630	Caesar R	Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism.	Journal of internal medicine	2010	42
21104225	3630	Yang BT	Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA(1c) levels in human pancreatic islets.	Diabetologia	2011	47
21216854	3630	Schmid AI	Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes.	Diabetes care	2011	36
21362568	3630	Smukler SR	The adult mouse and human pancreas contain rare multipotent stem cells that express insulin.	Cell stem cell	2011	58
21472114	3630	Canani RB	Potential beneficial effects of butyrate in intestinal and extraintestinal diseases.	World journal of gastroenterology	2011	100
21562325	3630	Steck AK	Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: diabetes autoimmunity study in the young.	Diabetes care	2011	56
21599535	3630	Leavens KF	Insulin signaling to hepatic lipid metabolism in health and disease.	Critical reviews in biochemistry and molecular biology	2011	37
21614570	3630	Camastra S	Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes.	Diabetologia	2011	37
21617152	3630	Sacks DB	Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.	Clinical chemistry	2011	56
21700865	3630	Cohen JC	Human fatty liver disease: old questions and new insights.	Science	2011	429
21864748	3630	Henquin JC	The dual control of insulin secretion by glucose involves triggering and amplifying pathways in β-cells.	Diabetes research and clinical practice	2011	42
21865645	3630	Ravassard P	A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion.	The Journal of clinical investigation	2011	72
22162232	3630	Li D	Diabetes and pancreatic cancer.	Molecular carcinogenesis	2012	53
22167125	3630	Dai C	Islet-enriched gene expression and glucose-induced insulin secretion in human and mouse islets.	Diabetologia	2012	53
22245737	3630	Bulek AM	Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetes.	Nature immunology	2012	48
22326434	3630	Cusi K	Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.	Gastroenterology	2012	112
22352879	3630	King AJ	The use of animal models in diabetes research.	British journal of pharmacology	2012	98
22425588	3630	Magkos F	Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects.	Gastroenterology	2012	34
22560210	3630	Jornayvaz FR	Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance.	Cell metabolism	2012	65
22740171	3630	Rezania A	Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice.	Diabetes	2012	98
22745242	3630	Gregg BE	Formation of a human β-cell population within pancreatic islets is set early in life.	The Journal of clinical endocrinology and metabolism	2012	76
22974438	3630	Rorsman P	Regulation of insulin secretion in human pancreatic islets.	Annual review of physiology	2013	74
23099275	3630	Kwon KC	Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.	Advanced drug delivery reviews	2013	35
23159341	3630	Shen J	The gut microbiota, obesity and insulin resistance.	Molecular aspects of medicine	2013	69
23524641	3630	Butler AE	Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors.	Diabetes	2013	90
23528347	3630	Sah RP	New insights into pancreatic cancer-induced paraneoplastic diabetes.	Nature reviews. Gastroenterology and hepatology	2013	40
23703888	3630	Lazo M	Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994.	American journal of epidemiology	2013	112
23787110	3630	Goh SK	Perfusion-decellularized pancreas as a natural 3D scaffold for pancreatic tissue and whole organ engineering.	Biomaterials	2013	36
23847240	3630	Wolpin BM	Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of pancreatic cancer.	Journal of the National Cancer Institute	2013	30
23929732	3630	Birkenfeld AL	Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes.	Hepatology	2014	70
23985870	3630	Le Chatelier E	Richness of human gut microbiome correlates with metabolic markers.	Nature	2013	375
24042324	3630	Ashcroft FM	K(ATP) channels and islet hormone secretion: new insights and controversies.	Nature reviews. Endocrinology	2013	41
24215793	3630	Mezza T	Insulin resistance alters islet morphology in nondiabetic humans.	Diabetes	2014	27
24241533	3630	Bojsen-Møller KN	Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass.	Diabetes	2014	25
24252877	3630	Lee J	Expansion and conversion of human pancreatic ductal cells into insulin-secreting endocrine cells.	eLife	2013	33
24256086	3630	Nobili V	Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance.	American journal of respiratory and critical care medicine	2014	20
24316517	3630	Vrieze A	Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.	Journal of hepatology	2014	48
24651807	3630	Cobelli C	The oral minimal model method.	Diabetes	2014	24
24899308	3630	Perry RJ	The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes.	Nature	2014	100
25176147	3630	Khan MT	Microbial modulation of insulin sensitivity.	Cell metabolism	2014	22
25211370	3630	Rezania A	Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells.	Nature biotechnology	2014	126
25448231	3630	Rastall RA	Recent developments in prebiotics to selectively impact beneficial microbes and promote intestinal health.	Current opinion in biotechnology	2015	23
25642774	3630	Herold KC	β cell death and dysfunction during type 1 diabetes development in at-risk individuals.	The Journal of clinical investigation	2015	30
25825943	3630	Schwarz JM	Effect of a High-Fructose Weight-Maintaining Diet on Lipogenesis and Liver Fat.	The Journal of clinical endocrinology and metabolism	2015	20
25894657	3630	Neis EP	The role of microbial amino acid metabolism in host metabolism.	Nutrients	2015	28
8988180	3651	Stoffers DA	Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence.	Nature genetics	1997	216
19255591	3651	Zhang D	Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells.	Cell research	2009	137
19287398	3651	Chen S	A small molecule that directs differentiation of human ESCs into the pancreatic lineage.	Nature chemical biology	2009	136
22570331	3651	Yang BT	Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with type 2 diabetes.	Molecular endocrinology	2012	50
23434589	3651	Bramswig NC	Epigenomic plasticity enables human pancreatic α to β cell reprogramming.	The Journal of clinical investigation	2013	104
24613355	3651	Chen YJ	De novo formation of insulin-producing "neo-β cell islets" from intestinal crypts.	Cell reports	2014	26
24633305	3651	Ardestani A	MST1 is a key regulator of beta cell apoptosis and dysfunction in diabetes.	Nature medicine	2014	34
25908839	3651	Russ HA	Controlled induction of human pancreatic progenitors produces functional beta-like cells in vitro.	The EMBO journal	2015	45
25918235	3651	Spijker HS	Loss of β-Cell Identity Occurs in Type 2 Diabetes and Is Associated With Islet Amyloid Deposits.	Diabetes	2015	17
7502040	3767	Inagaki N	Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor.	Science	1995	343
9038137	3767	Fan Z	Anionic phospholipids activate ATP-sensitive potassium channels.	The Journal of biological chemistry	1997	111
15115830	3767	Gloyn AL	Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.	The New England journal of medicine	2004	230
16885550	3767	Pearson ER	Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.	The New England journal of medicine	2006	189
18767144	3767	Flanagan SE	Update of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism.	Human mutation	2009	66
9438854	3815	Hirota S	Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.	Science	1998	672
17090188	3815	Miettinen M	Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis.	Archives of pathology and laboratory medicine	2006	262
17193820	3815	Miettinen M	Gastrointestinal stromal tumors: pathology and prognosis at different sites.	Seminars in diagnostic pathology	2006	236
18252749	3815	Akbar A	Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain.	Gut	2008	87
20226456	3815	Mekky MA	Diagnostic utility of EUS-guided FNA in patients with gastric submucosal tumors.	Gastrointestinal endoscopy	2010	49
22174191	3815	Nicolescu MI	Telocytes in parotid glands.	Anatomical record	2012	42
15720814	3845	Löhr M	Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis.	Neoplasia	2005	69
16931950	3845	Brune K	Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer.	The American journal of surgical pathology	2006	69
22266220	3845	O'Dell MR	Kras(G12D) and p53 mutation cause primary intrahepatic cholangiocarcinoma.	Cancer research	2012	33
22473163	3845	Dewdney A	Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C).	Journal of clinical oncology 	2012	49
22481281	3845	Chang DT	Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features.	Modern pathology 	2012	33
23295441	3845	Sia D	Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes.	Gastroenterology	2013	61
24681997	3845	Thege FI	Microfluidic immunocapture of circulating pancreatic cells using parallel EpCAM and MUC1 capture: characterization, optimization and downstream analysis.	Lab on a chip	2014	23
24928083	3845	Taieb J	Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial.	The Lancet. Oncology	2014	24
25706875	3845	Matano M	Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids.	Nature medicine	2015	74
26091037	3845	Dow LE	Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer.	Cell	2015	62
15793848	3855	Clouston AD	Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis.	Hepatology	2005	70
17631134	3855	Richardson MM	Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.	Gastroenterology	2007	85
18059363	3855	Rygiel KA	Epithelial-mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease.	Laboratory investigation; a journal of technical methods and pathology	2008	61
16696665	3938	Parvez S	Probiotics and their fermented food products are beneficial for health.	Journal of applied microbiology	2006	88
18724832	4051	Chang TT	Monolayer and spheroid culture of human liver hepatocellular carcinoma cell line cells demonstrate distinct global gene expression patterns and functional phenotypes.	Tissue engineering. Part A	2009	53
23483888	4051	Collino S	Metabolic signatures of extreme longevity in northern Italian centenarians reveal a complex remodeling of lipids, amino acids, and gut microbiota metabolism.	PloS one	2013	31
18549814	4513	Laine L	Gastric mucosal defense and cytoprotection: bench to bedside.	Gastroenterology	2008	79
19410194	4513	Cuzick J	Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement.	The Lancet. Oncology	2009	171
19487948	4513	Schneeweiss S	High-dimensional propensity score adjustment in studies of treatment effects using health care claims data.	Epidemiology	2009	164
20638563	4513	Chan FK	Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial.	Lancet	2010	42
23726390	4513	Coxib and traditional NSAID Trialists' (CNT) Collaboration.	Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials.	Lancet	2013	131
10910033	4843	Hussain SP	Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease.	Cancer research	2000	97
11978640	4843	Lupi R	Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated.	Diabetes	2002	113
20423716	4843	Saito C	c-Jun N-terminal kinase modulates oxidant stress and peroxynitrite formation independent of inducible nitric oxide synthase in acetaminophen hepatotoxicity.	Toxicology and applied pharmacology	2010	70
23077543	4843	Edin S	The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer.	PloS one	2012	83
10536005	5265	Morral N	Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons.	Proceedings of the National Academy of Sciences of the United States of America	1999	98
16183649	5265	Hidvegi T	Accumulation of mutant alpha1-antitrypsin Z in the endoplasmic reticulum activates caspases-4 and -12, NFkappaB, and BAP31 but not the unfolded protein response.	The Journal of biological chemistry	2005	66
20522742	5265	Hidvegi T	An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis.	Science	2010	157
21993621	5265	Yusa K	Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells.	Nature	2011	170
11309497	5465	Oliver WR Jr	A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport.	Proceedings of the National Academy of Sciences of the United States of America	2001	175
21183072	5465	Carone BR	Paternally induced transgenerational environmental reprogramming of metabolic gene expression in mammals.	Cell	2010	215
21397692	5465	White SS	Endocrine disrupting properties of perfluorooctanoic acid.	The Journal of steroid biochemistry and molecular biology	2011	37
22056763	5465	Tailleux A	Roles of PPARs in NAFLD: potential therapeutic targets.	Biochimica et biophysica acta	2012	46
26935695	5465	Beyaz S	High-fat diet enhances stemness and tumorigenicity of intestinal progenitors.	Nature	2016	32
9593295	6279	Akopyants NS	Analyses of the cag pathogenicity island of Helicobacter pylori.	Molecular microbiology	1998	173
10364597	6279	Yamaoka Y	Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries.	Journal of clinical microbiology	1999	136
14963045	6279	Higashi H	Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation.	The Journal of biological chemistry	2004	77
19798427	6279	Oldani A	Helicobacter pylori counteracts the apoptotic action of its VacA toxin by injecting the CagA protein into gastric epithelial cells.	PLoS pathogens	2009	50
18692929	6554	Cozzi L	A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy.	Radiotherapy and oncology 	2008	76
23150796	6554	Yan H	Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus.	eLife	2012	252
10573511	7018	Angulo P	Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.	Hepatology	1999	224
20080552	7018	Choi CH	Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles.	Proceedings of the National Academy of Sciences of the United States of America	2010	133
21855608	7018	Brissot P	Non-transferrin bound iron: a key role in iron overload and iron toxicity.	Biochimica et biophysica acta	2012	71
22327295	7018	Noinaj N	Structural basis for iron piracy by pathogenic Neisseria.	Nature	2012	57
19516192	7052	Myléus A	Celiac disease revealed in 3% of Swedish 12-year-olds born during an epidemic.	Journal of pediatric gastroenterology and nutrition	2009	49
22138844	7052	Volta U	Serological tests in gluten sensitivity (nonceliac gluten intolerance).	Journal of clinical gastroenterology	2012	35
7797011	7124	van Dullemen HM	Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).	Gastroenterology	1995	134
11156641	7124	Wigg AJ	The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis.	Gut	2001	123
11732005	7124	Crespo J	Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients.	Hepatology	2001	115
14988838	7124	Shintani Y	Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance.	Gastroenterology	2004	127
15996257	7124	Froud T	Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience.	American journal of transplantation 	2005	85
16022777	7124	Uiprasertkul M	Influenza A H5N1 replication sites in humans.	Emerging infectious diseases	2005	81
17241859	7124	Colombel JF	Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.	Gastroenterology	2007	221
18250193	7124	Armaka M	Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases.	The Journal of experimental medicine	2008	55
22684480	7124	Swan C	Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα.	Gut	2013	35
22842618	7124	Neurath MF	Mucosal healing in inflammatory bowel diseases: a systematic review.	Gut	2012	90
24056767	7124	Rungoe C	Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979-2011.	Gut	2014	27
24415859	7124	Pedersen J	Inflammatory pathways of importance for management of inflammatory bowel disease.	World journal of gastroenterology	2014	24
25125469	7124	Shoemark DK	The microbiome and disease: reviewing the links between the oral microbiome, aging, and Alzheimer's disease.	Journal of Alzheimer's disease 	2015	17
25535390	7124	He X	Cultivation of a human-associated TM7 phylotype reveals a reduced genome and epibiotic parasitic lifestyle.	Proceedings of the National Academy of Sciences of the United States of America	2015	28
26582965	7124	Michielan A	Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut.	Mediators of inflammation	2015	22
10858438	10062	Costet P	Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor.	The Journal of biological chemistry	2000	155
17936707	10062	Li X	SIRT1 deacetylates and positively regulates the nuclear receptor LXR.	Molecular cell	2007	197
15830281	10178	Llovet JM	Updated treatment approach to hepatocellular carcinoma.	Journal of gastroenterology	2005	121
19063642	10178	Chan EC	Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).	Journal of proteome research	2009	83
20564099	10178	Rice TW	Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals.	Cancer	2010	109
21523730	10178	Farges O	AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: By the AFC-IHCC-2009 study group.	Cancer	2011	41
25919911	10178	Zhang X	Elevated expression of CCAT2 is associated with poor prognosis in esophageal squamous cell carcinoma.	Journal of surgical oncology	2015	18
27313790	10178	Wang Y	The Long Noncoding RNA MALAT-1 is A Novel Biomarker in Various Cancers: A Meta-analysis Based on the GEO Database and Literature.	Journal of Cancer	2016	15
17980593	10413	Camargo FD	YAP1 increases organ size and expands undifferentiated progenitor cells.	Current biology 	2007	317
18703216	10413	Steinhardt AA	Expression of Yes-associated protein in common solid tumors.	Human pathology	2008	172
22042863	10413	Zhou D	Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance.	Proceedings of the National Academy of Sciences of the United States of America	2011	99
22677547	10413	Liu-Chittenden Y	Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP.	Genes and development	2012	210
22707013	10413	Zhang T	Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells.	Hepatology	2012	42
22886419	10413	Bai H	Yes-associated protein regulates the hepatic response after bile duct ligation.	Hepatology	2012	32
23143395	10413	Tumaneng K	YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29.	Nature cell biology	2012	87
23178811	10413	Barry ER	Restriction of intestinal stem cell expansion and the regenerative response by YAP.	Nature	2013	106
23762387	10413	Wang L	Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells.	PloS one	2013	55
24803537	10413	Zhang W	Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma.	Science signaling	2014	58
25293527	10413	Yu FX	Hippo pathway regulation of gastrointestinal tissues.	Annual review of physiology	2015	15
25453828	10413	Li Q	The conserved misshapen-warts-Yorkie pathway acts in enteroblasts to regulate intestinal stem cells in Drosophila.	Developmental cell	2014	23
25731159	10413	Taniguchi K	A gp130-Src-YAP module links inflammation to epithelial regeneration.	Nature	2015	61
25915126	10413	Cebola I	TEAD and YAP regulate the enhancer network of human embryonic pancreatic progenitors.	Nature cell biology	2015	25
25961504	10413	Iglesias-Bartolome R	Inactivation of a Gα(s)-PKA tumour suppressor pathway in skin stem cells initiates basal-cell carcinogenesis.	Nature cell biology	2015	18
26109051	10413	Chen Q	Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP.	Genes and development	2015	23
26193883	10413	Cai J	β-Catenin destruction complex-independent regulation of Hippo-YAP signaling by APC in intestinal tumorigenesis.	Genes and development	2015	20
27851739	10413	Gjorevski N	Designer matrices for intestinal stem cell and organoid culture.	Nature	2016	15
14699511	10599	Kullak-Ublick GA	Enterohepatic bile salt transporters in normal physiology and liver disease.	Gastroenterology	2004	85
19785645	10599	Kalliokoski A	Impact of OATP transporters on pharmacokinetics.	British journal of pharmacology	2009	113
21245207	10599	Niemi M	Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake.	Pharmacological reviews	2011	88
22232210	10599	van de Steeg E	Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver.	The Journal of clinical investigation	2012	42
24122874	10599	Prasad B	Interindividual variability in hepatic organic anion-transporting polypeptides and P-glycoprotein (ABCB1) protein expression: quantification by liquid chromatography tandem mass spectroscopy and influence of genotype, age, and sex.	Drug metabolism and disposition	2014	32
10544196	10803	Zabel BA	Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis.	The Journal of experimental medicine	1999	101
25027601	10803	Bakdash G	Retinoic acid primes human dendritic cells to induce gut-homing, IL-10-producing regulatory T cells.	Mucosal immunology	2015	31
25366965	10803	Wang J	Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation.	The Journal of experimental medicine	2014	26
25666191	10803	Mann ER	Compartment-specific immunity in the human gut: properties and functions of dendritic cells in the colon versus the ileum.	Gut	2016	13
17567459	10891	Pessayre D	Role of mitochondria in non-alcoholic fatty liver disease.	Journal of gastroenterology and hepatology	2007	59
18270681	10891	Ling C	Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion.	Diabetologia	2008	98
18680712	10891	Li S	Genome-wide coactivation analysis of PGC-1alpha identifies BAF60a as a regulator of hepatic lipid metabolism.	Cell metabolism	2008	60
19342452	10891	Thorn SR	Intrauterine growth restriction increases fetal hepatic gluconeogenic capacity and reduces messenger ribonucleic acid translation initiation and nutrient sensing in fetal liver and skeletal muscle.	Endocrinology	2009	48
22055504	10891	Timmers S	Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans.	Cell metabolism	2011	217
24411942	10891	Roberts LD	β-Aminoisobutyric acid induces browning of white fat and hepatic β-oxidation and is inversely correlated with cardiometabolic risk factors.	Cell metabolism	2014	64
25516156	10891	Blednov YA	Peroxisome proliferator-activated receptors α and γ are linked with alcohol consumption in mice and withdrawal and dependence in humans.	Alcoholism, clinical and experimental research	2015	19
15205477	23411	Cohen HY	Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase.	Science	2004	531
16098828	23411	Moynihan KA	Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice.	Cell metabolism	2005	197
18239056	23411	You M	Involvement of mammalian sirtuin 1 in the action of ethanol in the liver.	American journal of physiology. Gastrointestinal and liver physiology	2008	75
18662546	23411	Asher G	SIRT1 regulates circadian clock gene expression through PER2 deacetylation.	Cell	2008	332
22902550	23411	Castro RE	miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.	Journal of hepatology	2013	54
23257294	23411	Li X	SIRT1 and energy metabolism.	Acta biochimica et biophysica Sinica	2013	36
23696823	23411	Endo H	Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis.	PloS one	2013	33
24184811	23411	Li Y	Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21.	Gastroenterology	2014	33
25445538	23411	Szkudelski T	Resveratrol and diabetes: from animal to human studies.	Biochimica et biophysica acta	2015	15
10858549	26291	Nishimura T	Identification of a novel FGF, FGF-21, preferentially expressed in the liver.	Biochimica et biophysica acta	2000	142
19487637	26291	Chavez AO	Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance.	Diabetes care	2009	63
19702724	26291	Mraz M	Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.	Clinical endocrinology	2009	58
20451522	26291	Dushay J	Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease.	Gastroenterology	2010	102
20675007	26291	Li H	Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride.	Journal of hepatology	2010	66
20730630	26291	Itoh N	Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease.	Cell and tissue research	2010	46
22233381	26291	De Sousa-Coelho AL	Activating transcription factor 4-dependent induction of FGF21 during amino acid deprivation.	The Biochemical journal	2012	43
25083607	26291	Fisher FM	Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets.	Gastroenterology	2014	29
25476453	26291	Owen BM	Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21.	Trends in endocrinology and metabolism	2015	35
25577300	26291	Chen S	Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial.	Digestive and liver disease 	2015	18
17393509	26503	Angulo P	The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.	Hepatology	2007	235
18053320	26503	Klonoff DC	Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years.	Current medical research and opinion	2008	150
19013463	26503	Patton HM	Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis.	Gastroenterology	2008	50
23396737	26503	Wong VW	Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study.	Annals of hepatology	2013	39
23485521	26503	Bernstein DL	Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease.	Journal of hepatology	2013	35
23928932	26503	Venkatesh SK	Magnetic resonance elastography for the detection and staging of liver fibrosis in chronic hepatitis B.	European radiology	2014	30
25099546	26503	Chung M	Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis.	The American journal of clinical nutrition	2014	23
10693807	30061	Donovan A	Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter.	Nature	2000	285
10747949	30061	Abboud S	A novel mammalian iron-regulated protein involved in intracellular iron metabolism.	The Journal of biological chemistry	2000	235
16054062	30061	Donovan A	The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis.	Cell metabolism	2005	210
19416716	30061	Zhang DL	A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression.	Cell metabolism	2009	72
11113131	57817	Park CH	Hepcidin, a urinary antimicrobial peptide synthesized in the liver.	The Journal of biological chemistry	2001	329
19293425	57817	Theurl I	Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications.	Blood	2009	74
21572427	57817	Portugal S	Host-mediated regulation of superinfection in malaria.	Nature medicine	2011	85
22306005	57817	Ganz T	Hepcidin and iron homeostasis.	Biochimica et biophysica acta	2012	145
22703180	57817	Pantopoulos K	Mechanisms of mammalian iron homeostasis.	Biochemistry	2012	64
23139325	57817	Drakesmith H	Hepcidin and the iron-infection axis.	Science	2012	119
15940625	64092	Ratziu V	Sampling variability of liver biopsy in nonalcoholic fatty liver disease.	Gastroenterology	2005	272
18956295	64092	Wieckowska A	Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive.	Seminars in liver disease	2008	55
23665288	64092	Pais R	A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver.	Journal of hepatology	2013	57
11910337	64127	Cuthbert AP	The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease.	Gastroenterology	2002	116
12671896	64127	Hisamatsu T	CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells.	Gastroenterology	2003	135
12671897	64127	Rosenstiel P	TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells.	Gastroenterology	2003	78
14570728	64127	Ogura Y	Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis.	Gut	2003	95
15082587	64127	Ott SJ	Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease.	Gut	2004	226
15479689	64127	Wehkamp J	NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression.	Gut	2004	177
18305068	64127	Simms LA	Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.	Gut	2008	70
21343918	64127	Adler J	The prognostic power of the NOD2 genotype for complicated Crohn's disease: a meta-analysis.	The American journal of gastroenterology	2011	35
22349170	64127	Mukhopadhya I	IBD-what role do Proteobacteria play?	Nature reviews. Gastroenterology and hepatology	2012	82
22719818	64127	Li E	Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition.	PloS one	2012	60
19651814	80339	Kantartzis K	Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene.	Diabetes	2009	71
20034933	80339	He S	A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis.	The Journal of biological chemistry	2010	130
20803499	80339	Santoro N	A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents.	Hepatology	2010	48
22878467	80339	Pirazzi C	Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro.	Journal of hepatology	2012	38
22952180	80339	Sevastianova K	Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans.	The American journal of clinical nutrition	2012	36
20835230	114548	Masters SL	Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes.	Nature immunology	2010	281
23075849	114548	Huber S	IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine.	Nature	2012	120
23633957	114548	Negash AA	IL-1β production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease.	PLoS pathogens	2013	88
23955712	114548	Jourdan T	Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes.	Nature medicine	2013	63
24861026	114548	Wree A	NLRP3 inflammasome activation is required for fibrosis development in NAFLD.	Journal of molecular medicine	2014	30
25828455	114548	Macia L	Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome.	Nature communications	2015	53
26972847	114548	Iannitti RG	IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis.	Nature communications	2016	11
16400329	151306	Watanabe M	Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation.	Nature	2006	377
19346331	151306	Hylemon PB	Bile acids as regulatory molecules.	Journal of lipid research	2009	149
19582812	151306	Keitel V	The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders.	Hepatology	2009	47
21454404	151306	Li T	The G protein-coupled bile acid receptor, TGR5, stimulates gallbladder filling.	Molecular endocrinology	2011	44
21718300	151306	Parker HE	Molecular mechanisms underlying bile acid-stimulated glucagon-like peptide-1 secretion.	British journal of pharmacology	2012	46
22666533	151306	Harach T	TGR5 potentiates GLP-1 secretion in response to anionic exchange resins.	Scientific reports	2012	39
24411485	151306	Duboc H	The bile acid TGR5 membrane receptor: from basic research to clinical application.	Digestive and liver disease 	2014	28
24468803	151306	Joyce SA	The gut microbiota and the metabolic health of the host.	Current opinion in gastroenterology	2014	28
25584736	151306	Li T	Bile acids as metabolic regulators.	Current opinion in gastroenterology	2015	21
15331542	169026	Chimienti F	Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules.	Diabetes	2004	100
19450229	169026	Pound LD	Deletion of the mouse Slc30a8 gene encoding zinc transporter-8 results in impaired insulin secretion.	The Biochemical journal	2009	52
20858685	169026	Stene LC	Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the Diabetes and Autoimmunity Study in the Young (DAISY).	Diabetes	2010	57
21067382	169026	Knip M	Dietary intervention in infancy and later signs of beta-cell autoimmunity.	The New England journal of medicine	2010	57
24051378	169026	Tamaki M	The diabetes-susceptible gene SLC30A8/ZnT8 regulates hepatic insulin clearance.	The Journal of clinical investigation	2013	39
25015099	169026	Zhou Y	TCF7L2 is a master regulator of insulin production and processing.	Human molecular genetics	2014	28
20434452	282617	Honda M	Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C.	Gastroenterology	2010	134
21111740	282617	Dill MT	Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C.	Gastroenterology	2011	90
22248663	282617	Thomas E	HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons.	Gastroenterology	2012	97
23836238	282617	Horner SM	Regulation of hepatic innate immunity by hepatitis C virus.	Nature medicine	2013	82
26547499	282617	Wilder JM	Safety and efficacy of ledipasvir-sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data.	Hepatology	2016	10
11733350	100506658	Kucharzik T	Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins.	The American journal of pathology	2001	88
15236188	100506658	Cario E	Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C.	Gastroenterology	2004	98
16635908	100506658	Drago S	Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines.	Scandinavian journal of gastroenterology	2006	62
16644703	100506658	Sapone A	Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives.	Diabetes	2006	81
16822808	100506658	Zeissig S	Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease.	Gut	2007	197
22008894	100506658	Bertiaux-Vandaële N	The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype.	The American journal of gastroenterology	2011	40
23258127	100506658	Vaziri ND	Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease.	American journal of nephrology	2013	28
23357715	100506658	Vazquez-Roque MI	A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function.	Gastroenterology	2013	56
23878165	100506658	Vivinus-Nébot M	Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.	Gut	2014	39
